The place of intravenous immunoglobulin in rheumatic diseases

Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: N. V. Seredavkina, T. M. Reshetnyak, E. L. Nasonov
Format: Artigo
Sprache:Russo
Veröffentlicht: IMA-PRESS LLC 2016-01-01
Schriftenreihe:Современная ревматология
Schlagworte:
intravenous immunoglobulin
rheumatic diseases
Online Zugang:https://mrj.ima-press.net/mrj/article/view/655
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge